Mr. Bruce Daniels

Bruce Daniels - President
...
Bruce Daniels - President

Since 1975, Bruce Daniels has worked closely with hospitals and the physician community at large in various multi-dimensional senior level positions that include the "mission critical" functional areas of marketing, operations, new product development, sales, licensing and strategic business development.Prior to his joining Docsbackoffice, Mr. Daniels was President, Pall Biomedical Products Company division Pall Corporation, Vice President of Sales and Marketing to Wyndgate Technologies, developer of application-specific healthcare information management software, and Vice President of Sales and Marketing to Kentec Medical, a medical technologies distributor.In 1984, Mr. Daniels personally developed, licensed and marketed one of the first systems of its kind in intravenous therapy.In 1993 and 1994, he served as the President, Specialty Distributor Association, a national trade association comprised of medical distribution companies.

Bruce Daniels , President of Docsbackoffice said , Docsbackoffice.com requires a portal infrastructure that supports current initiatives , but is scalable , extensible and functionally robust to meet our current and future operational requirements for a dynamic B2B website.The Cytura healthcare orientation , leading edge technology and its software development capability will help enable Docsbackoffice to meet our short-term objectives , while providing a long-term , single vendor platform to support our organization's exciting e-healthcare vision..

About Cytura ( www.Cytura.com ) :Cytura Corporation is a growth-oriented , privately held company based in Orlando , Florida that provides next generation XML based software applications , tools , and services to create , deploy and manage industrial-strength Web portals that are content driven , interactive , personalized , and e-Commerce enabled.

About Docsbackoffice ( docsbackoffice.com ) :
...
Bruce DanielsPresident , Docsbackoffice.com516.768-9234bdaniels@docsbackoffice

Appoints Bruce Daniels to Position of VP of Sales and Marketing at Wyndgate Technologies

LAKEWOOD, Colo., July 27 /PRNewswire/ -- Global Med Technologies, Inc. (OTC Bulletin Board: GLOB - news; "Global Med") announced today the appointment of Bruce Daniels to the position of Vice President - Sales and Marketing for its Wyndgate Technologies division.

Mr. Daniels has extensive knowledge in both hospital and blood center transfusion practices.Most recently, Mr. Daniels was President - Pall Biomedical Products Company division, Pall Corporation (NYSE: PLL - news).In this capacity he directed the sales and marketing for Pall's hospital products in North America.These products included blood processing and transfusion sets for general use and leukocyte removal.Previously, Mr. Daniels was Vice President Sales and Marketing for fifteen years at Kentec Medical Inc., a regional specialty distributor, for medical devices, equipment and services.

"Mr. Daniels will report to Thomas F. Marcinek, President and COO of Global Med Technologies, Inc.Mr. Marcinek stated, "It will be great having Bruce on the Wyndgate team.His appointment is strategic to the successful launch and marketing of our new SafeTrace Tx(TM) product, as soon as we receive the U.S. Food and Drug Administration 510(k) market clearance.His knowledge of our customers and executive management experience will add a new dimension to our management team."

Commenting on his Wyndgate appointment Mr. Daniels said, "Helping regional blood centers and hospitals protect patients and improve the safety of the blood supply is very important to everyone.

Appoints Bruce Daniels to Position of VP of Sales and Marketing at Wyndgate Technologies

LAKEWOOD, Colo., July 27 /PRNewswire/ -- Global Med Technologies, Inc. (OTC Bulletin Board: GLOB - news; "Global Med") announced today the appointment of Bruce Daniels to the position of Vice President - Sales and Marketing for its Wyndgate Technologies division.

Mr. Daniels has extensive knowledge in both hospital and blood center transfusion practices.Most recently, Mr. Daniels was President - Pall Biomedical Products Company division, Pall Corporation (NYSE: PLL - news).In this capacity he directed the sales and marketing for Pall's hospital products in North America.These products included blood processing and transfusion sets for general use and leukocyte removal.Previously, Mr. Daniels was Vice President Sales and Marketing for fifteen years at Kentec Medical Inc., a regional specialty distributor, for medical devices, equipment and services.

"Mr. Daniels will report to Thomas F. Marcinek, President and COO of Global Med Technologies, Inc.Mr. Marcinek stated, "It will be great having Bruce on the Wyndgate team.His appointment is strategic to the successful launch and marketing of our new SafeTrace Tx(TM) product, as soon as we receive the U.S. Food and Drug Administration 510(k) market clearance.His knowledge of our customers and executive management experience will add a new dimension to our management team."

Commenting on his Wyndgate appointment Mr. Daniels said, "Helping regional blood centers and hospitals protect patients and improve the safety of the blood supply is very important to everyone.Wyndgate's SafeTrace(R) and SafeTrace Tx software products provide meaningful advancements to this process.I look forward to working closely with our customers and our alliance partners to dramatically increase Wyndgate sales through a customer focused and service-oriented marketing approach."

SafeTrace Tx is a transfusion management information system designed for use in hospitals and centralized transfusion service facilities to help ensure the safety and effectiveness of blood products administered to patient-recipients.SafeTrace Tx will help transfusion services manage patients, orders, blood product inventory and billing, as well as track all activities relating to blood product testing, preparation, movement and transfusion.SafeTrace Tx tracks blood products from the time they are received into inventory through the time they are transfused or returned to a supplying blood center.

Appoints Bruce Daniels to Position of VP of Sales and Marketing at Wyndgate Technologies.

LAKEWOOD, Colo., July 27 /PRNewswire / -- Global Med Technologies, Inc. (OTC Bulletin Board : GLOB - news ; ``Global Med'') announced today the appointment of Bruce Daniels to the position of Vice President - Sales and Marketing for its Wyndgate Technologies division.

Mr. Daniels has extensive knowledge in both hospital and blood center transfusion practices.Most recently, Mr. Daniels was President - Pall Biomedical Products Company division, Pall Corporation (NYSE : PLL - news).In this capacity he directed the sales and marketing for Pall's hospital products in North America.These products included blood processing and transfusion sets for general use and leukocyte removal.Previously, Mr. Daniels was Vice President Sales and Marketing for fifteen years at Kentec Medical Inc., a regional specialty distributor, for medical devices, equipment and services.

``Mr. Daniels will report to Thomas F. Marcinek, President and COO of Global Med Technologies, Inc.Mr. Marcinek stated, 'It will be great having Bruce on the Wyndgate team.His appointment is strategic to the successful launch and marketing of our new SafeTrace Tx (TM) product, as soon as we receive the U.S. Food and Drug Administration 510 (k) market clearance.His knowledge of our customers and executive management experience will add a new dimension to our management team.``.

Commenting on his Wyndgate appointment Mr. Daniels said, ``Helping regional blood centers and hospitals protect patients and improve the safety of the blood supply is very important to everyone.Wyndgate's SafeTrace (R) and SafeTrace Tx software products provide meaningful advancements to this process.I look forward to working closely with our customers and our alliance partners to dramatically increase Wyndgate sales through a customer focused and service-oriented marketing approach.''.

SafeTrace Tx is a transfusion management information system designed for use in hospitals and centralized transfusion service facilities to help ensure the safety and effectiveness of blood products administered to patient-recipients.SafeTrace Tx will help transfusion services manage patients, orders, blood product inventory and billing, as well as track all activities relating to blood product testing, preparation, movement and transfusion.SafeTrace Tx tracks blood products from the time they are received into inventory through the time they are transfused or returned to a supplying blood center.